ASX-listed Percheron Therapeutics, an international biotechnology company focused on developing novel therapies for oncology and rare diseases, has announced changes to the company’sexecutive leadership. Dr Michael Baker has been appointed…
Australia: Michael Baker to succeed James Garner as CEO at Percheron Therapeutics
…
…






